期刊： CURRENT PHARMACEUTICAL DESIGN, 2021; 27 (17)
Background: Drug-Target interactions are vital for drug design and drug repositioning. However, traditional lab experiments are both expensive and tim......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2021; 27 (7)
Background: Hypopharyngeal carcinoma is characterized by a high degree of malignancy. The most common pathological type is squamous cell carcinoma (HS......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2021; 27 (7)
Background: Glioma is the most common human central nervous system tumour with a high degree of malignancy. Some Rab GTPases have significant effects ......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2021; 27 (23)
Drug-drug interactions may occur when combining two or more drugs may cause some adverse events such as cardiotoxicity, central neurotoxicity, hepatot......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2021; 27 (13)
Introduction: The rapid emergence of Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) has resulted in an increased mortality rate across t......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2021; 27 (24)
Background: Epigenetic modifications have recently attracted much attention in the study of the biological mechanisms of Acute Myelocytic Leukemia (AM......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2021; 27 (26)
Cardiovascular disease is a major disease affecting human health, and its pathogenesis is caused by many factors. Through the use of "omics" technolog......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2021; 27 (25)
Chronic prostatitis/chronic pelvic pain syndrome type III is related to irritative voiding, sexual dysfunction, and pelvic pain. Chronic prostatitis/c......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2021; 27 (19)
At present, cancer is one of the most common diseases in the world, causing a large number of deaths and seriously affecting people's health. The trad......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2021; 27 (5)
One of the beneficial effects of molecular hydrogen (H-2, hydrogen gas) is neuroprotection and prevention of neurological disorders. It is important a......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2021; 27 (8)
Background: Rational drug molecular design based on virtual screening requires the ligand binding site to be known. Recently, the recognition of ion l......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2021; 27 (24)
Background: Hyperglycemia-induced microglia activation can cause a continuous release of proinflammatory cytokines, which gradually damages neurons an......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2021; 27 (29)
Background: Nonalcoholic fatty liver disease (NAFLD) is one of the most common reasons for the increase in serum alanine aminotransferase (ALT) and as......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2021; 27 (5)
The emerging field of hydrogen biology has to date mainly been applied in medicine. However, hydrogen biology can also enable positive outcomes in agr......
期刊： CURRENT PHARMACEUTICAL DESIGN, 2021; 27 (6)
According to the global statistics, the incidence of metabolic syndrome (MetS), which is a multifactorial disease with multiple risk factors, has reac......
